Gilead Sciences (GILD) Tops Q3 EPS by 21c, Offers Guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $124.87 +0.90%
EPS Growth %: -462.7%
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -462.7%
Financial Fact:
Shares used in per share calculation - basic: 1.32B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $1.84, $0.21 better than the analyst estimate of $1.63. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.38 billion.
GUIDANCE:
Gilead Sciences sees Q4 2018 revenue of $20.8-21.3 billion, versus the consensus of $21.43 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- NVE Corporation names new CEO and expands board to seven members
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
